IUL continues to be the strongest selling UL product. Companies have great profit/pricing expectations, but are those results being achieved? Learn about potential areas of underperformance for IUL including behavior related issues, hedging inefficiency, and mortality issues. The session will also discuss ways to monitor these risks and discuss different means to address potential issues of underperformance in hedging, pricing and in force earnings.